The NGS-Based RNA-Sequencing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the NGS-Based RNA-Sequencing Market?
The market size of the NGS-Based RNA-Sequencing Global Market Report 2025 has shown exponential growth recently. The market size increased from $3.41 billion in 2024 to $4.23 billion in 2025, indicating a compound annual growth rate (CAGR) of 24.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the NGS-Based RNA-Sequencing Industry?
The market size for NGS-based RNA-sequencing is projected to expand significantly and reach $10.4 billion in 2029. The forecasted compound annual growth rate (CAGR) is pegged at 25.2%.
Download Your Free Sample of the 2025 NGS-Based RNA-Sequencing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the NGS-Based RNA-Sequencing Market?
The key drivers in the ngs-based rna-sequencing market are:
• Growing use of NGS-based RNA-sequencing in clinical diagnostics
• Increased global collaborations in related scientific fields
• Strengthening of ethical and regulatory frameworks guiding research and application
• Expanding research in agriculture and environmental fields using this technology
Global Market Segmentation: Identifying Major NGS-Based RNA-Sequencing Industry Segments
The ngs-based rna-sequencing market covered in this report is segmented –
1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users
Pre-order the 2025 NGS-Based RNA-Sequencing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the NGS-Based RNA-Sequencing Market?
The key trends in the chemotherapy market are:
• Single-cell RNA-sequencing (scRNA-seq) is a significant emerging trend.
• Spatial transcriptomics is being increasingly utilized in this market.
• There is a rising trend of employing epitranscriptomics in RNA-sequencing.
• Multi-omics integration is shaping the future of the market.
Who Are the Top Competitors & Leading Players in the NGS-Based RNA-Sequencing Market?
Major companies in the ngs-based rna-sequencing market are:
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies Ltd.
• Agilent Technologies Inc.
• BGI Group
• QIAGEN N.V.
• PerkinElmer Inc.
• Eurofins Scientific SE
• Hamilton Company
• Takara Bio Inc.
• Tecan Trading AG
• GENEWIZ Inc.
• Novogene Corporation
• Macrogen Inc.
• Zymo Research Corp.
• Lexogen GmbH
• Partek Incorporated
• GATC Biotech AG
• Becton, Dickinson and Company
• Genohub LLC
• BaseClear B.V.
• Genewave SAS
• Otogenetics Corporation
• SeqLL LLC
• GenXPro GmbH
• Genotypic Technology Pvt. Ltd.
Regional Dominance: Which Area Leads the Global NGS-Based RNA-Sequencing Market?
North America was the largest region in the NGS-based RNA sequencing market in 2024
